| 1 |
8825 |
1,25 DIHYDROXY VITAMIN D3 |
RADIO IMMUNOASSAY |
SERUM FASTING |
3.0 ML (2.0 ML) |
"2-8 °C (24 hrs), F (> 24 hrs)" |
1,3,5: 1300 HRS |
NEXT DAY |
| 2 |
6020F |
14 Q32 / IGH GENE REARRANGEMENT |
FISH |
BONE MARROW HEPARIN / WHOLE BLOOD HEPARIN + CLINICAL HISTORY. SPECIMEN TO REACH US within 48 hrs AF |
3.0 ML ( 2.0 ML) |
"A" |
DAILY:1200 HRS |
5th Day |
| 3 |
3311 |
17-ALPHA HYDROXYPROGESTERONE (Neonatal Screening) |
ENZYME IMMUNOASSAY |
DRY BLOOD SPOT (With complete CLINICAL HISTORY form including birth date & birth time.) |
2.0 NOs (1.0 NOs) |
"2-8 °C (14 days)" |
1,4:1100 HRS |
NEXT DAY |
| 4 |
3313 |
17-ALPHA- HYDROXYPROGESTERONE |
CHROMATOGRAPHY / SPECTROPHOTOMETRY |
URINE -24 HOURS (Collected in 10 ML conc HCL; Mention 24 hrs. total volume on TRF) (Age & Sex of the |
15.0 ML (10.0 ML) |
"2-8 °C (15 days)" |
6: 1100 HRS |
SAME DAY |
| 5 |
3190 |
17-ALPHA- HYDROXYPROGESTERONE |
RADIO IMMUNOASSAY |
SERUM (Age & Sex required) |
0.5 ML (0.2 ML) |
"2-8 °C (4 days), F (>4days)" |
2,4: 1300 HRS |
SAME DAY |
| 6 |
7376 |
1p/ 19q deletion for Oligodendrogliomas by FISH FISH |
FISH |
1 Paraffin Block (malignant tissue embedded) and 1 hematoxylin-and-eosin stained slide. ( Paraffin e |
1+1 |
"AMBIENT" |
DAILY:1200HRS |
6TH DAY |
| 7 |
8823 |
25-HYDROXY VITAMIN D |
ECLIA |
SERUM Fasting |
1.0 ML (0.1 ML) |
"2-8 °C (48 HRS), F (> 48 HRS AT -20 DEGREE C)" |
DAILY: 1130 HRS |
SAME DAY |
| 8 | 9952 | 5-HYDROXY INDOLE ACETIC ACID | ENZYME IMMUNOASSAY | 24HRS URINE TO BE STRICTLY COLLECTED IN 15ML OF 6N HCL. * WHILE COLLECTING 24HRS URINE SPECIMEN, THE | 20.0 ML (10.0 ML) | "FROZEN STRICTLY" | 2nd & 4th TUESDAY : 1000HRS | NEXT DAY |
| 9 | 5110N | ABSOLUTE NEUTROPHIL COUNT | CELL COUNTER / MICROSCOPY | WB-EDTA + DIRECT BLOOD SMEAR | 3.0 ML (2.0) ML + 2 SMEARS | "A" | DAILY: 12:00,15:30,17:3 0 HRS | SAME DAY |
| 10 | 3114C | ACE CSF | SPECTROPHOTOMETRY | CSF + CLINICAL HISTORY | 1.0 (0.5) ML | "R/F" | 1st & 3rd MON : 1200 HRS | SAME DAY |
| 11 | 0011LS | ACETONE, SERUM | BIOCHEMISTRY | SERUM | 1.0 ML (0.5ML) | "R" | DAILY: 1600 HRS | 3RD DAY |
| 12 | 1336 | ACETONE, URINE | CHEMICAL ANALYSIS | URINE | 10.0 ML (5.0 ML) | "R" | 1,3,5 : 1300 HRS | SAME DAY |
| 13 | 1411 | ACETYLCHOLINE RECEPTOR AUTOANTIBODIES | RADIO IMMUNOASSAY | SERUM / EDTA- PLASMA | 1.0 ML (0.5 ML) + 1.0 ML (0.5 ML) | "2-8 °C (7 days)" | 1,3,5: 1100 HRS | SAME DAY |
| 14 | 1464BA | ACID FAST BACILLI CULTURE ( HEP WHOLE BLOOD & / BONE MARROW) | BACTEC METHOD | WB-HEPARIN/ BONE MARROW INOCULATED IN MYCO F LYTIC BACTEC BOTTLE | 10.0 ML (5.0 ML) IN MYCO F/ LYTIC BACTEC BOTTLE | "A" | DAILY:1000 HRS | WK 6 (Or when culture positive) |
| 15 | 1464 | ACID FAST BACILLI CULTURE: MGIT | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | ANY SPECIMEN of Pulmonary Origin IN STERILE CONTAINER/ | 3.0 ML (2.0) ML | "R" | DAILY: 1000 HRS | SMEAR - 48 HOURS & WK 6 (Or when culture positive) |
| 16 | 1464EP | ACID FAST BACILLI CULTURE: MGIT | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | ANY SPECIMEN of Non-Pulmonary Origin (except Blood & Bone marrow) IN STERILE CONTAINER/ TISSUE IN S | 3.0 ML (2.0) ML / 1 TISSUE | "R" | DAILY: 1000 HRS | SMEAR - 48 HOURS & WK 6 (Or when culture positive) |
| 17 | 1465 | ACID FAST BACILLI MGIT CULTURE (WITHOUT IDENTIFICATION TEST) | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | ANY SPECIMEN IN STERILE CONTAINER/ WHOLE BLOOD HEPARIN / TISSUE IN STERILE NORMAL SALINE /SWABS ARE | 3.0 ML (2.0) ML / 1 TISSUE | "R" | DAILY ( MON TO SAT): 1000 HRS | SMEAR - 48 HOURS & WK 6 (Or when culture positive) |
| 18 | 1464S | ACID FAST BACILLI, STAIN & MGIT CULTURE (3 SAMPLES) | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | SPUTUM/ URINE- STERILE CONTAINER | 3.0ML (0.5 ML) / 10.0 ML (5.0 ML) | "R" | DAILY:1500 HRS | SMEAR - SAME DAY (Or after last specimen is received & wk6 or when culture is positive) |
| 19 | 1464U | ACID FAST BACILLI, STAIN & MGIT CULTURE (5 SAMPLES) | FLUORESCENT STAIN / ZIEHL NEELSEN STAIN & MGIT 960+LJ CULTURE | SPUTUM/ URINE- STERILE CONTAINER | 3.0ML (0.5 ML) / 10.0 ML (5.0 ML) | "R" | DAILY:1500 HRS | SMEAR - SAME DAY (Or after last specimen is received & wk6 or when culture is positive) |
| 20 | 5901 | ACTIVATED PROTEIN C RESISTANCE | CLOT BASED | FASTING, CITRATED PLATELET POOR PLASMA* - AT MINUS 20 ° C *(DOUBLE CENTRIFUGED PLASMA)* with CL | TWO ALIQOUTS OF 1.5 ML EACH | "F (To be F immediately at - 20 °c & transported in dry ice)" | WEND / SAT 11:00HRS | SAME DAY |
| 21 | 9940 | ACTN3 GENOTYPING | PCR-RFLP | EDTA WHOLE BLOOD/ BUCCAL SWAB | 5 ML (3ML)/ 2 SWABS | "A" | 5: 1030 HRS | 9TH DAY |
| 22 | 7756 | ACUTE HEPATITIS VIRUS EVALUATION I (HCV ABS, HEV IgM, HBsAg, HAV IgM, HBcore IgM) | Chemiluminescent Microparticle Immunoassay (CMIA) / ENZYME IMMUNOASSAY | SERUM | 3.0 ML (2.0 ML) | "2-8 °C (7 days) ,>7 days -20 °C" | DAILY: 0730 HRS & 1530 HRS, EXCEPT FOR HEV IgM. DAILY 1130 HRS | SAME DAY |
| 23 | 7755 | ACUTE HEPATITIS VIRUS EVALUATION II (HCV ABS, HEV IgM / IgG, HBsAg, HAV IgM, HBeAg, HBeAb) | Chemiluminescent Microparticle Immunoassay (CMIA) / ENZYME IMMUNOASSAY | SERUM | 3.0 ML (2.0 ML) | "2-8 °C (7 days) ,>7 days -20 °C" | DAILY: 0730 HRS & 1530 HRS, EXCEPT FOR HEV IgM. DAILY 1130 HRS; HEV IgG: 3:11:30HRS | SAME DAY |
| 24 | 7757 | ACUTE HEPATITIS VIRUS EVALUATION III (HSV IgM, CMV IgM, EBV (EA) IgG, VZV IgM) | ENZYME IMMUNOASSAY | SERUM | 3.0 ML (2.0 ML) | "2-8 °C (7 days) ,>7 days -20 °C" | HSV IgM, CMV IgM--- DAILY:03:00HRS; EBV (EA) IgG--- 2,5:1100 HRS; VZV IgM--- 3:1100HRS | SAME DAY |
| 25 | 1608 | ACUTE LEUKEMIA PANEL (CD10,CD19,CD20,CD22,CD3,CD5, CD7,CD13,CD33,CD34,CD117,HLA DR, CYTOPLASMIC MARK | FLOW CYTOMETRY | BM / WB- EDTA | BM / WB- HEPARIN | FLUID-EDTA I FLUID-HEPARIN I BM / WB / FLUIDS DIRECT SMEARS + CLI | 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1 ML) | "A" | DAILY: 1530 HRS | NEXT DAY BY 6.00PM |
| 26 | 1606 | ACUTE LYMPHOBLASTIC LEUKEMIA PANEL (CD3,CD4,CD5,CD7,CD8,CD10,CD1 9,CD20,CD22,CD34,IgM, HLA-DR ,) | FLOW CYTOMETRY | BM / WB- EDTA | BM / WB- HEPARIN | FLUID-EDTA I FLUID-HEPARIN I BM / WB / FLUIDS DIRECT SMEARS + CLI | 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1 ML) | "A" | DAILY: 1530 HRS | NEXT DAY BY 6.00PM |
| 27 | 1047 | ACUTE MYELOID LEUKEMIA (AML) PANEL (CD7, CD19, CD13, CD14, CD15, CD33, CD34, CD117, CD41, CD61, GLYC | FLOW CYTOMETRY | BM / WB- EDTA | BM / WB- HEPARIN | FLUID-EDTA I FLUID-HEPARIN I BM / WB / FLUIDS DIRECT SMEARS + CL | 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1ML) / 3-4 ML (1 ML) | "A" | DAILY:1530 HRS | NEXT DAY BY 6.00PM |
| 28 | 5840 | ACUTE PROMYELOCYTIC LEUKEMIA (APL) | CELL CULTURE | BONE MARROW-HEPARIN / HEPARIN -WB+ SMEAR + CLINICAL HISTORY [Please mention the CLINICAL HISTORY, bl | 3.0 ML (2.0 ML) + 1-2 REPRESENTATIVE SLIDES | "A" | DAILY:1200 HRS | 10 working days |
| 29 | Z217 | ADENOCARCINOMA V/S MALIGNANT MESOTHELIOMA (CEA, EMA, VIMENTIN, LWCK)[PHOTO] | IMMUNOHISTOCHEMISTRY | TISSUE IN 10%FORMALIN / PARAFIN BLOCK (Site of biopsy & Clinical details mandatory)MANDATORY IF TISS | 1 CM / 1 BLOCK | "A" | DAILY:1100 HRS | 3RD DAY |
| 30 | 3131 | ADENOSINE DEAMINASE (ADA) | SPECTROPHOTOMETRY | SERUM, PLEURAL FLUID, ASCITIC FLUID, CSF, PERICARDIAL FLUID, PERITONEAL FLUID & OTHER BODY FLUIDS ( | 1.0 (0.5) ML, 2.0 (1.0) ML, 2.0 (1.0), 2.0 (1.0) ML, 2.0 (1.0) ML | "F" | DAILY: 1200 HOURS | SAME DAY |
| 31 | 9921I | ADENOVIRUS IgG | ENZYME IMMUNOASSAY | SERUM | 0.50 ML (0.25 ML) | "2-8 °C (5 days); -70°C to - 20 °C (>5 days)" | 1ST FRI: 1030 HRS | NEXT DAY |
| 32 | 9924I | ADENOVIRUS IgM | ENZYME IMMUNOASSAY | SERUM | 0.50 ML (0.25 ML) | "2-8 °C (5 days); -70°C to - 20 °C (>5 days)" | 1ST FRI: 1030 HRS | NEXT DAY |
| 33 | 7589 | ADENOVIRUS PCR | POLYMERASE CHAIN REACTION | SWABS: (ORAL, EYE, NASAL) / RESPIRATORY FLUIDS | 1.0 (0.5) ML | "A" | 2:1000 HOURS | 5 : 1800 HRS |
| 34 | 9938RD | ADRB2 GENOTYPING FOR B-2- AGONIST RESPONSIVENESS | PCR-SEQUENCING | EDTA WHOLE BLOOD + CLINICAL HISTORY | 5 ML (3 ML) | "A" | 1: 1030 HRS | 6TH DAY |
| 35 | 9951U | ADRENALIN URINE | ELISA | RANDOM URINE / 24HRS URINE with (Preservative:10 - 15ML 6N HCL) & mention the TOTAL VOLUME. MIX THES | 10.0 ML | "F FROZEN STRICTLY" | 2nd & 4th WEDNESDAY : 1000HRS | NEXT DAY |
| 36 | 9951P | ADRENALIN, PLASMA | ELISA | THE BLOOD SAMPLE SHOULD BE STORED AT 2-8 DEGREE CELCIUS UNTIL CENTRIFUGED TO SEPARATE THE PLASMA WIT | 2.0 ML (1.0 ML) | "F FROZEN STRICTLY" | 2nd & 4th WEDNESDAY : 1000HRS | NEXT DAY |
| 37 | 3102 | ADRENOCORTICOTROPIC HORMONE (ACTH) - COMPLETE | CHEMILUMINESCENCE | PLASMA-EDTA ( Freeze the specimen immediately after separation. Specimen collected between 6-10 am i | 2.0 ML (0.5 ML) | "F" | 2,4: 0430,1430,1600 HRS | SAME DAY |
| 38 | Z161K | ADRENOCORTICOTROPIC HORMONE (ACTH) [PHOTO] | IMMUNOHISTOCHEMISTRY | TISSUE IN 10%FORMALIN / PARAFFIN BLOCK (Site of biopsy & Clinical details mandatory)MANDATORY IF TIS | 1 CM / 1 BLOCK | "A" | DAILY:1100 HRS | 3RD DAY |
| 39 | 3103 | ADRENOCORTICOTROPIC HORMONE (ACTH) STIMULATION TEST - 1 HOUR | CHEMILUMINESCENCE | 250ug Synacthen IM/IV 3 Serum Samples Collected 1/2 HR.Apart Basal (before drug) , 30min, 60min (Fre | 1.0 ML (0.5 ML) | "F" | DAILY: 0430,1430,1600 HRS | SAME DAY |
| 40 | 1212 | AEROBIC BLOOD CULTURE - BACTEC | BACTEC FLUORESCENT METHOD | WB- HEPARIN / INOCULATED BACTEC BOTTLE (AEROBIC PLUS ) | 5.0 ML (2.0 ML) | "A" | DAILY: 1700 HRS | PRELIM. 2ND DAY, FINAL 7TH DAY |
| 41 | 1221CS | AEROBIC CULTURE- ISOLATION & IDENTIFICATION (Culture + Sensitivity) | CULTURE + SENSITIVITY BY MIC BREAKPOINT | SCRAPINGS / PUS/ TISSUE IN SALINE-STERILE CONTAINER(Swabs not accepted) | SCRAPINGS / 3.0 ML (0.5 ML) | "R" | DAILY: 1700 HRS | 3RD DAY |
| 42 | 1212P | AEROBIC PAEDIATRIC CULTURE BLOOD- BACTEC | BACTEC FLUORESCENT METHOD | INOCULATED BACTEC BOTTLE (AEROBIC PLUS ) | 3.0 ML (0.5 ML) | "A" | DAILY: 1700 HRS | PRELIM. 2ND DAY, FINAL 7TH DAY |
| 43 | CA5654 | AFB SUSCEPTIBILITY : Capreomycin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 44 | CI5654 | AFB SUSCEPTIBILITY : Ciprofloxacin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 45 | ET5654 | AFB SUSCEPTIBILITY : Ethambutol | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 46 | EH5654 | AFB SUSCEPTIBILITY : Ethionamide | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY 1000 HRS | 15 DAYS |
| 47 | IS5654 | AFB SUSCEPTIBILITY : Isoniazid | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 48 | KA5654 | AFB SUSCEPTIBILITY : Kanamycin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 49 | LV5654 | AFB SUSCEPTIBILITY : Levofloxacin | BACTEC MGIT-960 METHOD | PURE FRESHLY SUB-CULTURED M. TUBERCULOSIS ISOLATE (ISOLATE IDENTIFICATION REPORT FROM THE REFERRING | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE (Isolate Identification report from the r | "R" | DAILY:1000 HRS | 15 DAYS |
| 50 | LZ5654 | AFB SUSCEPTIBILITY : LINEZOLID | BACTEC MGIT-960 METHOD | CULTURE | PURE & FRESHLY SUBCULTURED M. TUBERCULOSIS COMPLEX ISOLATE | "R" | DAILY:1000 HRS | 15 DAYS |